Lotus To Commercialize Glenmark’s Ryaltris Nasal Spray In SE Asia

Allergic Rhinitis Treatment Will Be Sold Across Singapore, Hong Kong And Vietnam

Glenmark is set to roll out its allergic rhinitis nasal spray Ryaltris in three South East Asian countries following an exclusive licensing agreement with Lotus. The company expects Ryaltris to have a significant role to play in its growth over the coming years.

Man using nasal spray
Allergic rhinitis has a prevalence of 4.2% in Hong Kong, 4.9% in Singapore and 12.3% in Vietnam • Source: Alamy

More from Value Added Medicines

More from Products